CW December 2000
Volume 9Issue Number 12 December 2000 ISSN 10593802 BAX to the FutureIdentifying the mechanisms by which chemotherapy agents kill tumor cells is critical for the efficient use of such anticancer drugs. A recent study pinpoints BAX, a member of the Bcl-2 family of proteins, as a key player in apoptosis induced by nonsteroidal anti-inflammatory drugs (NSAID) used to treat colorectal cancer.
Go to Previous Page Go to Next Page Source & Additional Reading Zhang, Yu, Park, Kinzler and Vogelstein. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW December 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
